Johnson & Johnson (JNJ)

$149.12 0.00 (0.00%)

19:00 EDT JNJ Stock Quote Delayed 30 Minutes

3 Dividend Stocks to Buy Now for Lifelong Income

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 22, 2024

Here are three dividend stocks to buy now offering stability, growth, and lifelong income in the pharmaceutical and tobacco industries.

5 Crash-Proof Stocks to Buy Immediately

Investing for the Long-Term: 3 Stocks With Proven Track Records

Recession-Proof Riches: 3 Stocks That Thrive in Any Economy

Volume:

Previous Close -

Market Cap 391.99B

PE Ratio -

EPS -

Volume (Avg. Vol.) 524

Day's Range -

52-Week Range $143.13 - $175.97

Dividend & Yield $4.76 (3.19%)

JNJ Stock Predictions, Articles, and Johnson & Johnson News

From InvestorPlace
From the Web

Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.

By Joel Baglole, InvestorPlace Contributor Apr 18, 2024

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

Put $10,000 in These 3 Dividend Stocks by 2025

By Vandita Jadeja Apr 17, 2024

In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income.

JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings Apr 16, 2024

JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash

By Rich Duprey, InvestorPlace Contributor Apr 14, 2024

You never know when a downturn will hit so it pays to prepare for the worst by buying these stocks before a market crash.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

All-Time High Flyers: 7 Stocks to Buy as the Market Peaks

By Joel Baglole, InvestorPlace Contributor Apr 11, 2024

These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.

Why Is Rallybio (RLYB) Stock Up 93% Today?

By William White, InvestorPlace Writer Apr 11, 2024

Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.

Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 10, 2024

These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

By Josh Enomoto, InvestorPlace Contributor Apr 10, 2024

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access…

If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names

By Michael Que, InvestorPlace Contributor Apr 10, 2024

The economy is performing pretty well, investing in these top dividend stocks to buy will guarantee good profits.

SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson

By Dana Blankenhorn, InvestorPlace Contributor Apr 5, 2024

JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff.

3 Value Stocks to Buy on the Dip: March 2024

By Josh Enomoto, InvestorPlace Contributor Mar 28, 2024

If you’ve been following the headlines, you’ll be well aware of the value behind value stocks to buy. Basically, the smart money sees some risks…

7 Dow Stocks to Buy on the Dip: March 2024

By Ian Bezek, InvestorPlace Contributor Mar 27, 2024

Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back.

7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis

By Josh Enomoto, InvestorPlace Contributor Mar 26, 2024

With the equities market seemingly soaring to one plateau after another, bringing up dividend aristocrat stocks seems overly cautious. These ideas represent companies that have…

Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500

By Muslim Farooque, InvestorPlace Contributor Mar 25, 2024

Invest in these three top S&P 500 stocks to buy offering healthy upside as the Fed signals triple rate cut later this year.

7 Dividend Darlings to Scoop Up Every Time the Market Dips

By Vandita Jadeja Mar 24, 2024

These dividend stocks are some of the best in the industry and they are worth loading up on every single market dip.

Wall Street’s Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich

By Faizan Farooque, InvestorPlace Contributor Mar 21, 2024

Wall Street's favorite long-term stocks JNJ, KO, and CAT offer a blend of dividend reliability, sector diversity, and strong market presence

Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own

By Vandita Jadeja Mar 16, 2024

Investing in your golden years is about choosing stocks for retirees that are low-risk, offer passive income and steadily grow.

The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough

By Faizan Farooque, InvestorPlace Contributor Mar 15, 2024

Transform tax time tensions with tax season stocks; choose from JNJ's dividends, EQIX's REIT perks, or TSLA's growth for tax efficiency.

The 3 Most Undervalued Healthcare Stocks to Buy in March 2024

By Muslim Farooque, InvestorPlace Contributor Mar 14, 2024

Wager on these promising undervalued healthcare stocks, catering to investors aiming to leverage growth within the dynamic healthcare space

J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family

From Bloomberg Apr 20, 2024

Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product.

Johnson & Johnson (JNJ)

3 Dividend Stocks to Buy Now for Lifelong Income

5 Crash-Proof Stocks to Buy Immediately

Investing for the Long-Term: 3 Stocks With Proven Track Records

Recession-Proof Riches: 3 Stocks That Thrive in Any Economy

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Johnson & Johnson (JNJ)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

JNJ Stock Predictions, Articles, and Johnson & Johnson News

Subscriber Sign in